REGENERON PHARMACEUTICALS, INC. Current Liabilities 2009-2026 | REGN
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is REGENERON PHARMACEUTICALS, INC.'s current current liabilities?
REGENERON PHARMACEUTICALS, INC. (REGN) annual current liabilities for 2025 was $4.37B, a 10.75% increase from 2024. REGENERON PHARMACEUTICALS, INC. current liabilities for the quarter ending March 31, 2026 was $5.11B.
What was REGENERON PHARMACEUTICALS, INC.'s current liabilities in 2024?
REGENERON PHARMACEUTICALS, INC. annual current liabilities for 2024 was $3.94B, a 15.22% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s current liabilities in 2023?
REGENERON PHARMACEUTICALS, INC. annual current liabilities for 2023 was $3.42B, a 8.98% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year current liabilities CAGR?
REGENERON PHARMACEUTICALS, INC. current liabilities grew at a compound annual growth rate (CAGR) of 10.12% from FY2020 to FY2025, going from $2.70B to $4.37B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.37B | +10.8% | 10-K |
| FY2024 | $3.94B | +15.2% | 10-K |
| FY2023 | $3.42B | +9.0% | 10-K |
| FY2022 | $3.14B | -20.1% | 10-K |
| FY2021 | $3.93B | +45.8% | 10-K |
| FY2020 | $2.70B | +28.7% | 10-K |
| FY2019 | $2.10B | +45.3% | 10-K |
| FY2018 | $1.44B | +27.1% | 10-K |
| FY2017 | $1.14B | -8.5% | 10-K |
| FY2016 | $1.24B | +53.1% | 10-K |
| FY2015 | $811.2M | +23.9% | 10-K |
| FY2014 | $654.7M | +119.1% | 10-K |
| FY2013 | $298.8M | +82.7% | 10-K |
| FY2012 | $163.6M | +10.3% | 10-K |
| FY2011 | $148.3M | +36.0% | 10-K |
| FY2010 | $109.1M | +16.5% | 10-K |
| FY2009 | $93.6M | - | 10-K |